-
Something wrong with this record ?
Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery
G. Vizzielli, R. Naik, L. Dostalek, N. Bizzarri, A. Kucukmetin, G. Tinelli, G. Scambia, D. Cibula,
Language English Country United States
Document type Journal Article
NLK
Free Medical Journals
from 1994 to 24 months ago
ProQuest Central
from 1997-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2009-07-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-01-01 to 1 year ago
- MeSH
- Adult MeSH
- Pelvic Exenteration * MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasm Recurrence, Local pathology surgery MeSH
- Survival Rate MeSH
- Pelvic Neoplasms pathology surgery MeSH
- Genital Neoplasms, Female pathology surgery MeSH
- Follow-Up Studies MeSH
- Postoperative Complications * MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
PURPOSE: To evaluate morbidity and oncological outcome in a multicentre series of women with gynaecological malignancies infiltrating pelvic side wall (PSW) that received laterally extended pelvic resection (LEPR). METHODS: Patients operated between 2007 and 2017 at three institutions were included. LEPR was defined as an en bloc lateral resection of a pelvic tumour involving sidewall muscle, and/or bone, and/or major nerve, and/or major vascular structure. Postsurgical complications and survivals were evaluated. RESULTS: Sixty-three women with gynaecological tumours involving PSW were treated with LEPR. Five women underwent primary LEPR, whereas 58 (92%) patients needed LEPR because of recurrence. Twenty-four women (38%) received previous radiation therapy before the surgery. R0 resection was achieved in 54 patients (85.7%), whereas the pathologic margins were microscopically and macroscopically positive in 8 (12.7%) patients and 1 (1.6%) patient, respectively. There was one perioperative death, whereas major postoperative complications occurred in 17 patients (27.7%). Thirty (47.5%) women experienced recurrences: 24/54 (44.4%) were in the R0 group, and 6/9 (66.6%) were in the R1 group, with a median PFS of 15 months and 7 months, respectively (p = 0.024). In total, 11 of 54 (20.3%) patients died of disease in the R0 group and 5 of 9 (55.5%) in the R1 group; a median OS was not reached and was 32 months for R0 and R1 groups, respectively (p = 0.033). CONCLUSIONS: Involvement of the PSW should not prevent obtaining R0 resection. Although the LEPR is associated with considerable morbidity (≈ 30%), a long-term survival seems to be achieved in those women with complete resection.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027996
- 003
- CZ-PrNML
- 005
- 20190816101431.0
- 007
- ta
- 008
- 190813s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1245/s10434-018-07088-8 $2 doi
- 035 __
- $a (PubMed)30539489
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vizzielli, Giuseppe $u Department of Women's and Children's Health, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. giuseppevizzielli@yahoo.it.
- 245 10
- $a Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery / $c G. Vizzielli, R. Naik, L. Dostalek, N. Bizzarri, A. Kucukmetin, G. Tinelli, G. Scambia, D. Cibula,
- 520 9_
- $a PURPOSE: To evaluate morbidity and oncological outcome in a multicentre series of women with gynaecological malignancies infiltrating pelvic side wall (PSW) that received laterally extended pelvic resection (LEPR). METHODS: Patients operated between 2007 and 2017 at three institutions were included. LEPR was defined as an en bloc lateral resection of a pelvic tumour involving sidewall muscle, and/or bone, and/or major nerve, and/or major vascular structure. Postsurgical complications and survivals were evaluated. RESULTS: Sixty-three women with gynaecological tumours involving PSW were treated with LEPR. Five women underwent primary LEPR, whereas 58 (92%) patients needed LEPR because of recurrence. Twenty-four women (38%) received previous radiation therapy before the surgery. R0 resection was achieved in 54 patients (85.7%), whereas the pathologic margins were microscopically and macroscopically positive in 8 (12.7%) patients and 1 (1.6%) patient, respectively. There was one perioperative death, whereas major postoperative complications occurred in 17 patients (27.7%). Thirty (47.5%) women experienced recurrences: 24/54 (44.4%) were in the R0 group, and 6/9 (66.6%) were in the R1 group, with a median PFS of 15 months and 7 months, respectively (p = 0.024). In total, 11 of 54 (20.3%) patients died of disease in the R0 group and 5 of 9 (55.5%) in the R1 group; a median OS was not reached and was 32 months for R0 and R1 groups, respectively (p = 0.033). CONCLUSIONS: Involvement of the PSW should not prevent obtaining R0 resection. Although the LEPR is associated with considerable morbidity (≈ 30%), a long-term survival seems to be achieved in those women with complete resection.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a nádory ženských pohlavních orgánů $x patologie $x chirurgie $7 D005833
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a lokální recidiva nádoru $x patologie $x chirurgie $7 D009364
- 650 12
- $a exenterace pánve $7 D010385
- 650 _2
- $a nádory pánve $x patologie $x chirurgie $7 D010386
- 650 12
- $a pooperační komplikace $7 D011183
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Naik, Raj $u Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
- 700 1_
- $a Dostalek, Lukas $u Gynaecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Bizzarri, Nicolò $u Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
- 700 1_
- $a Kucukmetin, Ali $u Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
- 700 1_
- $a Tinelli, Giovanni $u Division of Vascular Surgery, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
- 700 1_
- $a Scambia, Giovanni $u Department of Women's and Children's Health, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
- 700 1_
- $a Cibula, David $u Gynaecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
- 773 0_
- $w MED00000441 $t Annals of surgical oncology $x 1534-4681 $g Roč. 26, č. 2 (2019), s. 523-530
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30539489 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190816101701 $b ABA008
- 999 __
- $a ok $b bmc $g 1433145 $s 1066456
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 26 $c 2 $d 523-530 $e 20181211 $i 1534-4681 $m Annals of surgical oncology $n Ann Surg Oncol $x MED00000441
- LZP __
- $a Pubmed-20190813